Microsoft shares have climbed back to within striking distance of their all-time high, carried by a six-quarter streak of earnings beats and a commercial backlog that jumped 84 percent to $678 billion. The rally prices in a lot of AI optimism, but the company is also guiding to roughly $116 billion of capital expenditure this cycle while free cash flow declines, a gap that the next quarterly report will have to start closing.
The backlog is the only hard number
Commercial remaining performance obligations surged to $678 billion, up 84 percent from the prior period. That figure represents contracted future revenue, not a forecast, and it is the cleanest evidence that enterprises are committing to Microsoft’s cloud and AI stack at scale. The rest of the investment case rests on Azure growth rates and Copilot adoption curves that the company breaks out only selectively.
The spending side is less tidy
Analysts expect capex of about $116 billion for the current cycle. Free cash flow has been falling even as the spending accelerates, which means the return-on-invested-capital conversation is moving from theoretical to urgent. The street has tolerated the divergence so far because the backlog keeps expanding, but tolerance is not a valuation model.
Enterprise trust is the moat argument
Melius Research upgraded the stock to Buy with a $665 price target, arguing that Microsoft’s existing governance, security, and software relationships make it the default choice for large corporations deploying AI. That is a plausible structural advantage, but it is also the same argument that once justified a premium for on-premise license maintenance, a business that eventually compressed.
The next test arrives October 28
The October 28 earnings report will be judged on four lines: Azure constant-currency growth, AI-attributable revenue, capex trajectory, and free cash flow conversion. Six consecutive beats have bought credibility, but the bar has moved from beating consensus to proving that the $116 billion buildout generates incremental margin rather than just incremental revenue. The market is currently pricing the former; the financial statements will eventually have to confirm it.